Q4-FY26 · Ashoke Nyak
Our revenue from operations grew by 23.6% along with 48% increase in EBITDA and 58.1% increase in PAT excluding exceptional items.
RPGLIFESCIENCES / language trends
Read confidence between the lines.
RPG Life Sciences · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q4-FY26 · Ashoke Nyak
We have a very clear road map on this on what exactly we need to do. We quantify the exposure with clear triggers, confirm where we stand today, and summarize the mitigation actions already under way.
Q4-FY26 · Ashoke Nyak
We would actually seek approval only when there is a significant basket of product with strong market share in the US... the company is also mindful of the cost benefit equation.